Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Byrne

Showing results (31-40 of 458) with videos related to

Pageof 46
Sort By:
Arteriosclerosis, Thrombosis, and Vascular Biology|September 25, 2015
Gallstone Disease and Increased Risk of Ischemic Heart Disease: Causal Association or Epiphenomenon?Giovanni Targher, Christopher D Byrne
Gastroenterology|November 26, 2015
Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver DiseaseChristopher D Byrne, Giovanni Targher
Journal of Hepatology|December 15, 2017
Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction?Christopher D Byrne, Gianluca Perseghin
Gut|September 12, 2021
Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is neededChristopher D Byrne, Giovanni Targher
Nature Reviews. Nephrology|February 21, 2017
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney diseaseGiovanni Targher, Christopher D Byrne
Pathophysiology of Haemostasis and Thrombosis|August 1, 2006
Effects of VLDL and remnant particles on plateletsRasaq Olufadi, Christopher D Byrne
Clinical and Molecular Hepatology|December 9, 2020
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver diseaseErica Jennison, Christopher D Byrne
Faculty Reviews|May 8, 2023
Recent advances in NAFLD: current areas of contentionErica Jennison, Christopher D Byrne
European Heart Journal|December 5, 2019
Treatment algorithm in patients with type 2 diabetes and atherosclerotic cardiovascular disease or high/very high cardiovascular riskGiovanni Targher, Christopher D Byrne
Hepatology (Baltimore, Md.)|October 22, 2015
Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogramGiovanni Targher, Christopher D Byrne
Pageof 46

Showing results (31-40 of 458) with videos related to

Sort By:
Pageof 46
Arteriosclerosis, Thrombosis, and Vascular Biology|September 25, 2015
Gallstone Disease and Increased Risk of Ischemic Heart Disease: Causal Association or Epiphenomenon?Giovanni Targher, Christopher D Byrne
Gastroenterology|November 26, 2015
Time to Replace Assessment of Liver Histology With MR-Based Imaging Tests to Assess Efficacy of Interventions for Nonalcoholic Fatty Liver DiseaseChristopher D Byrne, Giovanni Targher
Journal of Hepatology|December 15, 2017
Non-alcoholic fatty liver disease: A risk factor for myocardial dysfunction?Christopher D Byrne, Gianluca Perseghin
Gut|September 12, 2021
Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is neededChristopher D Byrne, Giovanni Targher
Nature Reviews. Nephrology|February 21, 2017
Non-alcoholic fatty liver disease: an emerging driving force in chronic kidney diseaseGiovanni Targher, Christopher D Byrne
Pathophysiology of Haemostasis and Thrombosis|August 1, 2006
Effects of VLDL and remnant particles on plateletsRasaq Olufadi, Christopher D Byrne
Clinical and Molecular Hepatology|December 9, 2020
The role of the gut microbiome and diet in the pathogenesis of non-alcoholic fatty liver diseaseErica Jennison, Christopher D Byrne
Faculty Reviews|May 8, 2023
Recent advances in NAFLD: current areas of contentionErica Jennison, Christopher D Byrne
European Heart Journal|December 5, 2019
Treatment algorithm in patients with type 2 diabetes and atherosclerotic cardiovascular disease or high/very high cardiovascular riskGiovanni Targher, Christopher D Byrne
Hepatology (Baltimore, Md.)|October 22, 2015
Nonalcoholic fatty liver disease, cardiovascular outcomes, and mortality in patients undergoing a coronary angiogramGiovanni Targher, Christopher D Byrne
Pageof 46